Form 4: American Healthcare REIT Director Valerie Richardson Granted Restricted Stock Upon Re-election

Valerie Richardson, a Director of American Healthcare REIT, Inc., was granted 3,042 shares of restricted common stock on June 25, 2025, following her re-election to the board.

Summary

• Valerie Richardson, a Director of American Healthcare REIT, Inc. (AHR), was the reporting person in this SEC Form 4 filing.
• On June 25, 2025, Ms. Richardson was granted 3,042 shares of restricted common stock.
• This grant occurred upon her re-election as a director to the board of directors of American Healthcare REIT, Inc.
• The granted shares of restricted common stock are scheduled to vest on June 25, 2026.
• Following this transaction, Valerie Richardson beneficially owns a total of 18,062 shares of common stock in American Healthcare REIT, Inc.

Sentiment

Score: 7

Explanation: The filing reports a routine, expected insider transaction (director re-election and equity grant) which is generally positive for corporate governance and alignment of interests, but does not contain significant new financial performance data that would dramatically alter sentiment.

Positives

• Director Valerie Richardson's re-election signifies continuity and stability in the company's corporate governance.
• The grant of restricted stock aligns the director's financial interests with the long-term performance and shareholder value creation of American Healthcare REIT, Inc., as the shares vest over time.

Risks

• The 3,042 shares of restricted common stock granted to Valerie Richardson are subject to a vesting period until June 25, 2026, meaning full ownership is contingent on her continued service to the company until that date.

Future Outlook

The grant of restricted stock to Director Valerie Richardson, with a vesting date of June 25, 2026, implies an expectation of her continued tenure and commitment to the company's long-term strategic objectives and performance.

Industry Context

This Form 4 filing details a routine equity compensation event for a director within the Real Estate Investment Trust (REIT) sector. Granting restricted stock upon re-election is a common practice across industries, including REITs, to align the interests of board members with those of shareholders and to incentivize long-term value creation. This transaction is consistent with standard corporate governance practices.

Comparison to Industry Standards

• The grant of restricted stock to a director upon re-election is a standard compensation mechanism widely adopted across various industries, including the REIT sector, to align director incentives with shareholder interests.
• While specific comparable companies or projects are not detailed in this filing, such equity grants are a typical component of director compensation packages.
• The one-year vesting period for the restricted stock is also a common timeframe for such grants, reflecting a balance between immediate compensation and long-term commitment.

Management Changes

Corporate Governance

Related Party Transactions

• The grant of restricted common stock to Valerie Richardson, a director, constitutes a related party transaction, which is a standard and disclosed form of director compensation.

Stakeholder Impact

• Shareholders: The equity grant aligns the director's long-term interests with those of shareholders, potentially fostering decisions that enhance shareholder value.
• Employees: No direct impact on general employees is indicated by this filing.
• Customers: No direct impact on customers is indicated by this filing.
• Suppliers: No direct impact on suppliers is indicated by this filing.
• Creditors: No direct impact on creditors is indicated by this filing.

Next Steps

• The 3,042 shares of restricted common stock granted to Valerie Richardson are scheduled to vest on June 25, 2026.

Key Dates

Keywords

American Healthcare REIT, AHR, SEC Form 4, insider transaction, restricted stock, director compensation, corporate governance, equity grant, Valerie Richardson